Prof. xiangwen peng – Proteomics – Best Researcher Award

Prof. xiangwen peng – Proteomics – Best Researcher Award

Changsha Maternal and Child Health Hospital affiliated to Hunan Normal University, China

Author Profile

orcid

🎓 Academic Background

Prof. Xiangwen Peng pursued his Ph.D. in Heart Regeneration at Fudan University, Shanghai, China (2011-2016), where he conducted groundbreaking research on heart regeneration under the mentorship of Dr. Tao P. Zhong. Prior to this, he obtained his Master’s degree from Hunan Normal University, Changsha, China (2006-2009), focusing on Drosophila heart development under the guidance of Dr. Xiushan Wu and Dr. Rolf Bodmer. His academic journey began with a Bachelor’s degree in Aquaculture from Guangdong Ocean University, Guangdong, China (2001-2005), laying the foundation for his expertise in biological sciences.

🏥 Leadership in Hospital Research Development

Since October 2021, Prof. Xiangwen Peng has been serving as the Central Laboratory Director at Changsha Maternal and Child Health Hospital, affiliated with Hunan Normal University. His primary responsibility is the establishment and development of the hospital’s basic research center, which integrates both clinical and fundamental research to enhance medical advancements. Under his leadership, a multidisciplinary research platform has been created, covering zebrafish and mouse experimental models, cell biology, and molecular biology studies.

🧬 Postdoctoral and International Research Experience

Prof. Peng’s research career has been enriched by several postdoctoral and visiting scholar positions at prestigious institutions worldwide. He worked as a Postdoctoral Researcher at the Institute of Pediatrics, Guangzhou Women and Children’s Medical Centre, Guangzhou Medical University (2016-Present), where he focused on the role of noncanonical Wnt signaling in zebrafish heart regeneration. Between 2019 and 2020, he conducted postdoctoral research at the Medical College of Wisconsin, deepening his expertise in cardiac research. Prior to that, he worked as a Visiting Scholar at the McAllister Heart Institute, University of North Carolina at Chapel Hill (2018-2019), where he explored immune cell involvement in zebrafish heart regeneration, specifically T cell immunity, and gained valuable experience in single-cell research techniques.

🚀 Vision for Future Scientific Growth

Prof. Xiangwen Peng is dedicated to advancing medical research in maternal and child health. His evidence-based approach to hospital development is already yielding remarkable results, reinforcing his commitment to building a research-oriented hospital that integrates scientific innovation, clinical excellence, and academic leadership. Through his continuous efforts, he is paving the way for future medical breakthroughs and improved patient care.

Notable Publications📝


📝Identification of CSPG4 as a Biomarker and Therapeutic Target for Infantile Post‐Hemorrhagic Hydrocephalus via Multi‐Omics Analysis

Authors: Juncao Chen, Lin Wang, Xiangwen Peng, Tingting Cheng, Yihui Yang, Jingzhen Su, Hongmei Zou, Siyao Wang, Yueting Mao, Lixiang Wu, et al.

Journal: Advanced Science

Year: 2025


📝A patient with 18p11.32-p11.21 deletion have monaural deafness caused by an inadequate haplodose of THOC1: A case report

Authors: Geng Ouyang, Enhuan Yi, Huali Qin, Xingxing Duan, Sifeng Wang, Xiangwen Peng

Journal: Medicine

Year: 2024


📝Case Report: Wiedemann-Steiner syndrome with a new frameshift mutation in KMT2A

Authors: Jun He, Aimin Deng, Ying Chen, Shuyuan Yan, Yanling Wang, Tuanmei Wang, Xiangwen Peng

Journal: Preprint

Year: 2024


📝The clinical spectrum of a nonsense mutation in KAT6A: a case report

Authors: Dongbo Wang, Jun He, Xueyi Li, Shuyuan Yan, Linglin Pan, Tuanmei Wang, Liangrong Zhou, Jiyang Liu, Xiangwen Peng

Journal: Journal of International Medical Research

Year: 2022


📝Neomodified Koyanagi technique for severe hypospadias with one‐stage sealed Y‐shaped penis foreskin vascular protection surgery

Authors: Jiancheng Zu, Yifu Chen, Yu Liu, Tianqu He, Yanling Wang, Yuee Zu, Xiangwen Peng

Journal: Clinical Case Reports

Year: 2022

Prof. Chungang Liu | Proteomics | Best Researcher Award

Prof. Chungang Liu | Proteomics | Best Researcher Award

Professor at Chongqing Medical University, China

Professional Profiles

Scopus

Orcid

🎓Academic and Professional Background

Chungang LIU is currently an Investigator at Chongqing Medical University. He earned his Ph.D. from the School of Medicine at Zhejiang University, focusing on cancer stem cells and cell division. His postdoctoral training was at the IMCB of A*STAR, where he identified and characterized several proteins involved in protein homeostasis through ubiquitination modification, including the SOX9 and YTHDF1 complexes. In 2019, he became an independent investigator at the Third Military Medical University and was appointed A*STAR IMCB Research Fellow. In January 2021, he moved his laboratory to the Second Affiliated Hospital, Chongqing Medical University.

🔗Professional Memberships

Prof. Chungang Liu is a distinguished member of the Chinese Society of Cell Biology. His active involvement in this professional community reflects his dedication to advancing research in the field of cell biology. His contributions to understanding the molecular mechanisms of protein post-translational modifications and cancer research align with the mission of the Society to promote scientific discovery and innovation. Prof. Liu’s expertise in epigenetics and cancer stem cells continues to foster valuable exchanges within this prominent scientific network.

🔬Research Areas

Chungang LIU’s research focuses on Protein Post-Translational Modification and Functional Regulation. His team uses integrative proteomics to uncover how epigenetic modifying enzymes drive cancer treatment tolerance. They also explore how inhibitors of these enzymes can enhance the effectiveness of Sorafenib or immune checkpoint blockade (ICB) treatment. Additionally, Chungang’s lab has revealed the molecular mechanisms of ubiquitination modification regulating target protein homeostasis and inhibiting the symmetric division of cancer stem cells.

Publications Top Noted📝

  • GASC1 promotes hepatocellular carcinoma progression by inhibiting the degradation of ROCK2
    • Authors: Na Shao, Jiamin Cheng, Hong Huang, Feng Xu, Chungang Liu
    • Journal: Cell Death and Disease
    • Year: 2021
  • KEAP1 Mutations Drive Tumorigenesis by Suppressing SOX9 Ubiquitination and Degradation
    • Authors: Na Shao, Hong Huang, Muhammad Idris, Shiwu Dong, Chungang Liu
    • Journal: Advanced Science
    • Year: 2020

Mr. Rahul Dey, Proteomics, Best Researcher Award

Mr. Rahul Dey, Proteomics, Best Researcher Award

Mr. Rahul Dey, CSIR–Indian Institute Of Chemical Technology, India

Profiles

Scopus

🌟Summary

Rahul Dey is a dedicated Research Fellow at CSIR-Indian Institute of Chemical Technology, specializing in transcriptional regulations and cellular therapy. His work focuses on understanding molecular mechanisms in diseases like psoriasis and leveraging bioinformatics tools to advance therapeutic strategies.

🎓Education

Master of Science in Biochemistry and Molecular Biology
Pondicherry University, India (Jul 2017 – Jun 2019)
Dissertation: Cytotoxic effect of Lycorine on Saccharomyces cerevisiae mutants

Bachelor of Science (Honours) in Zoology
University of Calcutta, India (Jul 2014 – Jun 2017)
Modules included microbiology, recombinant DNA technology, and bioinformatics.

👩‍🔬Professional Experience

Research Fellow
CSIR-Indian Institute of Chemical Technology, Hyderabad (Aug 2021 – Present)

Conducted research on transcriptional regulations in mesenchymal stem cells for psoriasis.

Utilized bioinformatics tools for NCBI GEO datasets analysis and DEG identification.

Handled cell culture, lentivirus production, and rodent models for preclinical studies.

🔬Research Interests

Cell Biology & Molecular Biology 🧫

Bioinformatics & Data Analysis 💻

Transcriptional Regulation & Stem Cell Therapy 🔬

Disease Modeling & Therapeutics 🌟

🧪Technical Skills

Cell Culture: Human and murine primary cell culture, handling, and differentiation.

Bioinformatics Tools: DAVID, Cytoscape, NCBI GEO datasets analysis.

Molecular Biology Techniques: Western blotting, qRT-PCR, gene cloning, and microscopy.

Programming: R programming, GraphPad Prism.

🏆Awards and Recognition

CSIR/UGC-National Eligibility Test (NET) Fellowship: All India Rank 102

Graduate Aptitude Test in Engineering (GATE): All India Rank 880

Publication📝

An integrated bioinformatics approach for unravelling the molecular insights into psoriasis pathology and therapeutics

Authors: Dey, R., Das, A.

Journal: Gene Reports

Year: 2024